International Journal of Clinical Research
International Journal of Clinical Research. 2025; 9: (4) ; 10.12208/j.ijcr.20250205 .
总浏览量: 50
1 西藏大学医学院 西藏拉萨
2 拉萨市人民医院 西藏拉萨
*通讯作者: 卓玛拉吉,单位: 西藏大学医学院 西藏拉萨;
目的 对高原地区慢性心力衰竭伴房颤患者的NT-proBNP水平及其临床相关性进行初步研究。方法对高原地区的200例慢性心力衰竭患者的住院病历资料进行了回顾性研究,将患者分为房颤组与非房颤组,并进行对比分析。结果 共纳入200例慢性心力衰竭患者,发现房颤组与非房颤组在NT-proBNP水平、左心房内径、左心室舒张末内径及左心室射血分数方面具有统计学差异(p<0.05);慢性心力衰竭患者NT-proBNP水平与左心房内径呈正相关(r=0.63 p<0.05),与左心室舒张末内径呈负相关(r=-0.16 p<0.05),与左心室射血分数也呈负相关(r=-0.28 p<0.05)。结论 在慢性心力衰竭的临床评估中,NT-proBNP水平可反映心室的重构及心功能情况;当慢性心力衰竭患者合并出现房颤时,其NT-proBNP水平会进一步升高,因此该指标可以作为高原地区慢性心力衰竭合并房颤患者早期预测的参考依据。
Objective To study the level of NT-proBNP and its clinical correlation in chronic heart failure patients with atrial fibrillation in high altitude area. Methods The inpatient records of 200 patients with chronic heart failure in plateau area were retrospectively studied, and the patients were divided into atrial fibrillation group and non-atrial fibrillation group. Results A total of 200 patients with chronic heart failure were included. It was found that there were statistical differences in NT-proBNP level, left atrial diameter, left ventricular end-diastolic diameter and left ventricular ejection fraction between AF group and non-AF group (p < 0.05). The level of NT-proBNP in patients with chronic heart failure was positively correlated with left atrial diameter (r=0.63 p < 0.05), negatively correlated with left ventricular end-diastolic diameter (r=-0.16 p < 0.05), and negatively correlated with left ventricular ejection fraction (r=-0.28 p < 0.05). Conclusion In the clinical evaluation of chronic heart failure, the level of NT-proBNP can reflect ventricular remodeling and cardiac function. When chronic heart failure patients with atrial fibrillation, the level of NT-proBNP will be further increased, so this index can be used as a reference for early prediction of chronic heart failure patients with atrial fibrillation in plateau areas.
[1] 李先武,黄道桂.氨基末端B型利钠肽前体、白细胞介素-6及血管紧张素Ⅱ联合评估慢性心力衰竭患者不良预后的效能分析[J].大医生,2025,10(06):93-96.
[2] 杨亚慧.慢性心力衰竭血清肌钙蛋白Ⅰ、肌红蛋白、N末端脑钠肽前体水平变化及其临床意义[J].罕少疾病杂志, 2025, 32(02):67-68+72.
[3] 卢敏,杨继俊,罗水光,等.顽固性心力衰竭患者NT-proBNP与肺超声B线、下腔静脉变异度、左室射血分数、APACHEⅡ评分的相关性分析[J].临床医学研究与实践,2025, 10(05): 41-44.
[4] 刘洋,韩敏,曹雪明.抗心力衰竭治疗前后NT-proBNP、PDGF联合Adropin改变率预测预后的效能研究[J].海南医学,2025,36(03):391-395.
[5] 孙洪洋,姜阳,王婷.慢性心力衰竭患者心脏彩超参数、血浆cMyBP-C水平变化及临床意义研究[J].检验医学与临床,2025,22(02):198-202+209.
[6] 张双霞,朱秋洁.血小板反应蛋白2及N末端B型钠尿肽前体在射血分数保留型心力衰竭中的临床价值分析[J].临床研究,2025,33(02):148-151.
[7] 张媛媛,赵志杰,刘青,等.血清NT-pro-BNP、IGFBP-7和CTRP12在慢性心力衰竭患者中的水平及意义[J].检验医学与临床,2025,22(01):107-111+118.
[8] 孙明,胡贤军,韩永生.慢性心力衰竭患者白蛋白降低与NT-proBNP升高和长期预后不良的相关性分析[J].中国循证心血管医学杂志,2024,16(12):1546-1549.
[9] 韩江.N末端B型脑钠肽前体、白细胞介素-6、血管紧张素Ⅱ与慢性心力衰竭预后及患者心功能的相关性分析[J].大医生,2025,10(02):122-124.
[10] 李娜,曹若雪,姚丽.BUN/Cr、cTnⅠ、NT-proBNP在不同严重程度的急性左心衰竭患者中的诊断价值[J].中国医学创新,2025,22(01):153-157.